http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100469085-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-61 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 |
filingDate | 2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100469085-B1 |
titleOfInvention | 3,4,5-Trifluoropyridine derivatives, its preparation and antiviral pharmaceutical composition comprising the same |
abstract | The present invention relates to a 3,4,5-trifluoropyridine derivative useful as an antiviral agent, and a novel 3,4, represented by the following general formula (1) having an excellent antiproliferative effect of Hepatitis C virus (HCV): It relates to a 5-trifluoropyridine derivative, a pharmaceutically acceptable salt thereof, a preparation method thereof and an antiviral pharmaceutical composition comprising the compound as an active ingredient. The novel 3,4,5-trifluoropyridine derivative represented by Formula 1 according to the present invention is excellent in inhibiting the proliferation of hepatitis C virus (HCV) and less toxic, thus preventing and treating hepatitis C. It can be usefully used as.n n n [Formula 1]n n n n n n n n In Chemical Formula 1, R represents a C 1 -C 4 straight or crushed alkyl group, C 2 -C 6 straight or crushed dialkylamino group, trifluoromethyl group, pyridyl group or substituted phenyl group. |
priorityDate | 2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 348.